BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37315868)

  • 1. Progesterone receptor isoform ratios influence the transcriptional activity of progestins via the progesterone receptor.
    Cartwright M; Louw-du Toit R; Jackson H; Janse van Vuuren M; Africander D
    J Steroid Biochem Mol Biol; 2023 Sep; 232():106348. PubMed ID: 37315868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transcriptional activity of progestins used in contraception and menopausal hormone therapy via progesterone receptor A is dependent on the density of the receptor.
    Cartwright M; Toit RL; Africander D
    Biochem Biophys Res Commun; 2023 Jan; 639():70-76. PubMed ID: 36470074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of an estrogen receptor-regulated gene by first generation progestins requires both the progesterone receptor and estrogen receptor alpha.
    Perkins MS; Louw-du Toit R; Jackson H; Simons M; Africander D
    Front Endocrinol (Lausanne); 2022; 13():959396. PubMed ID: 36187129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progestogens exhibit progestogen-, promoter- and isoform-specific effects via the progesterone receptor.
    Enfield K; Avenant C; Hapgood JP
    Steroids; 2022 Nov; 187():109094. PubMed ID: 35905833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progestins and breast cancer hallmarks: The role of the ERK1/2 and JNK pathways in estrogen receptor positive breast cancer cells.
    Louw-du Toit R; Simons M; Africander D
    J Steroid Biochem Mol Biol; 2024 Mar; 237():106440. PubMed ID: 38048919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of progestins used in hormonal contraception and progesterone via the progesterone receptor.
    Enfield K; Cartwright M; Toit RL; Avenant C; Africander D; Hapgood JP
    Biochem Biophys Res Commun; 2020 Dec; 533(4):879-885. PubMed ID: 33008590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors.
    Chen FP; Chien MH; Chen HY; Huang TS; Ng YT
    Taiwan J Obstet Gynecol; 2013 Sep; 52(3):365-73. PubMed ID: 24075375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells.
    Ruan X; Neubauer H; Yang Y; Schneck H; Schultz S; Fehm T; Cahill MA; Seeger H; Mueck AO
    Climacteric; 2012 Oct; 15(5):467-72. PubMed ID: 22335423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors.
    Salazar M; Lerma-Ortiz A; Hooks GM; Ashley AK; Ashley RL
    Gene; 2016 Oct; 591(1):6-13. PubMed ID: 27349565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nortestosterone-derived synthetic progestogens do not activate the progestogen receptor of Murray-Darling rainbowfish (Melanotaenia fluviatilis) but are potent agonists of androgen receptors alpha and beta.
    Bain PA; Kumar A; Ogino Y; Iguchi T
    Aquat Toxicol; 2015 Jun; 163():97-101. PubMed ID: 25863598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A direct comparison of the transcriptional activities of progestins used in contraception and menopausal hormone therapy via the mineralocorticoid receptor.
    Louw-du Toit R; Hapgood JP; Africander D
    Biochem Biophys Res Commun; 2020 May; 526(2):466-471. PubMed ID: 32234237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
    Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
    Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells.
    Bray JD; Jelinsky S; Ghatge R; Bray JA; Tunkey C; Saraf K; Jacobsen BM; Richer JK; Brown EL; Winneker RC; Horwitz KB; Lyttle CR
    J Steroid Biochem Mol Biol; 2005 Dec; 97(4):328-41. PubMed ID: 16157482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An amino-terminal truncated progesterone receptor isoform, PRc, enhances progestin-induced transcriptional activity.
    Wei LL; Hawkins P; Baker C; Norris B; Sheridan PL; Quinn PG
    Mol Endocrinol; 1996 Nov; 10(11):1379-87. PubMed ID: 8923464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-proliferative transcriptional effects of medroxyprogesterone acetate in estrogen receptor positive breast cancer cells are predominantly mediated by the progesterone receptor.
    Moore NL; Hanson AR; Ebrahimie E; Hickey TE; Tilley WD
    J Steroid Biochem Mol Biol; 2020 May; 199():105548. PubMed ID: 31805393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A).
    Africander DJ; Storbeck KH; Hapgood JP
    J Steroid Biochem Mol Biol; 2014 Sep; 143():404-15. PubMed ID: 24861265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential metabolism of clinically-relevant progestogens in cell lines and tissue: Implications for biological mechanisms.
    Skosana SB; Woodland JG; Cartwright M; Enfield K; Komane M; Louw-du Toit R; van der Spuy Z; Avenant C; Africander D; Storbeck KH; Hapgood JP
    J Steroid Biochem Mol Biol; 2019 May; 189():145-153. PubMed ID: 30822501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproductive epidemiology of glial tumors may reveal novel treatments: high-dose progestins or progesterone antagonists as endocrino-immune modifiers against glioma.
    Altinoz MA; Ozpinar A; Elmaci I
    Neurosurg Rev; 2019 Jun; 42(2):351-369. PubMed ID: 29453736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone receptor expression in medroxyprogesterone acetate-induced murine mammary carcinomas and response to endocrine treatment.
    Helguero LA; Viegas M; Asaithamby A; Shyamala G; Lanari C; Molinolo AA
    Breast Cancer Res Treat; 2003 Jun; 79(3):379-90. PubMed ID: 12846422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP.
    Sartorius CA; Groshong SD; Miller LA; Powell RL; Tung L; Takimoto GS; Horwitz KB
    Cancer Res; 1994 Jul; 54(14):3868-77. PubMed ID: 8033109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.